1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Thelial Technologies S.A. - Product Pipeline Review - 2016

Thelial Technologies S.A. - Product Pipeline Review - 2016

  • February 2016
  • -
  • Global Markets Direct
  • -
  • 26 pages

Thelial Technologies S.A. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Thelial Technologies S.A. - Product Pipeline Review - 2016’, provides an overview of the Thelial Technologies S.A.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Thelial Technologies S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Thelial Technologies S.A.
- The report provides overview of Thelial Technologies S.A. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Thelial Technologies S.A.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Thelial Technologies S.A.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Thelial Technologies S.A.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Thelial Technologies S.A.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Thelial Technologies S.A.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table Of Contents

Thelial Technologies S.A. - Product Pipeline Review - 2016
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Thelial Technologies S.A. Snapshot 5
Thelial Technologies S.A. Overview 5
Key Information 5
Key Facts 5
Thelial Technologies S.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Thelial Technologies S.A. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Thelial Technologies S.A. - Pipeline Products Glance 10
Thelial Technologies S.A. - Early Stage Pipeline Products 10
Discovery Products/Combination Treatment Modalities 10
Thelial Technologies S.A. - Unknown Stage Pipeline Products 11
Unknown Products/Combination Treatment Modalities 11
Thelial Technologies S.A. - Drug Profiles 12
The-103 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
The-104 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
The-105 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
The-106 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
The-107 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
The-108 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
The-109 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
The-110 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
The-111 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
The-124 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
Thelial Technologies S.A. - Pipeline Analysis 22
Thelial Technologies S.A. - Pipeline Products by Route of Administration 22
Thelial Technologies S.A. - Pipeline Products by Molecule Type 23
Thelial Technologies S.A. - Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 25
Disclaimer 26

List of Tables
Thelial Technologies S.A., Key Information 5
Thelial Technologies S.A., Key Facts 5
Thelial Technologies S.A. - Pipeline by Indication, 2016 7
Thelial Technologies S.A. - Pipeline by Stage of Development, 2016 8
Thelial Technologies S.A. - Monotherapy Products in Pipeline, 2016 9
Thelial Technologies S.A. - Discovery, 2016 10
Thelial Technologies S.A. - Unknown, 2016 11
Thelial Technologies S.A. - Pipeline by Route of Administration, 2016 22
Thelial Technologies S.A. - Pipeline by Molecule Type, 2016 23

List of Figures
Thelial Technologies S.A. - Pipeline by Indication, 2016 7
Thelial Technologies S.A. - Pipeline by Stage of Development, 2016 8
Thelial Technologies S.A. - Monotherapy Products in Pipeline, 2016 9
Thelial Technologies S.A. - Pipeline by Molecule Type, 2016 23

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

Pulmonary Fibrosis - Pipeline Review, H2 2016

Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape. ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.